“…C 2 symmetric HIV protease, and was modeled after the corresponding carbinol 45 reported by Merck [47]. Testing of 44, 45 and the commercial HIV protease inhibitor indinavir (not shown) found them to inhibit the enzyme to a similar degree, with K i values of 2.7 nM, 0.38 nM and 0.37 nM, respectively [48]. In addition, IC 90 values for protection of whole cells against HIV infection gave parallel values, indicating that they all penetrated cell membranes to the same degree, thereby demonstrating the drug-like properties of silanediol 44.…”